norfluoxetine has been researched along with Premenstrual Syndrome in 1 studies
norfluoxetine: metabolite of fluoxetine; RN given refers to parent cpd without isomeric designation
Premenstrual Syndrome: A combination of distressing physical, psychologic, or behavioral changes that occur during the luteal phase of the menstrual cycle. Symptoms of PMS are diverse (such as pain, water-retention, anxiety, cravings, and depression) and they diminish markedly 2 or 3 days after the initiation of menses.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Stewart, DE | 1 |
| Fairman, M | 1 |
| Barbadoro, S | 1 |
| Zownir, P | 1 |
| Steiner, M | 1 |
1 trial available for norfluoxetine and Premenstrual Syndrome
| Article | Year |
|---|---|
Follicular and late luteal phase serum fluoxetine levels in women suffering from late luteal phase dysphoric disorder.
Topics: Adult; Double-Blind Method; Female; Fluoxetine; Follicular Phase; Humans; Luteal Phase; Middle Aged; | 1994 |